McAndrews, Held & Malloy

Back to News Releases

	07/18/2006 McAndrews, Held & Malloy Secures Summary Judgment for Client Alaris
	CHICAGO, IL – July 18, 2006 – McAndrews, Held & Malloy announced today that it has secured a major victory for its client Alaris Medical Systems Inc., a business unit of Cardinal Health, Inc. [NYSE: CAH], which provides leading-edge intravenous infusion systems. Yesterday, the U.S. District Court for the Central District of California granted partial summary judgment of noninfringement on behalf of McAndrews, Held & Malloy client Alaris. The case involves four patents relating to a needle-free valve that can transfer drugs, blood and other fluids to and from a patient through intravenous tubing. ICU Medical, Inc. [NASDAQ: ICUI], a manufacturer of disposable medical connection systems for use in intravenous therapy applications, filed suit in June of 2004 against Alaris. The suit alleged that Alaris’ SmartSite® Valve and SmartSite® Plus Valve infringed on ICU’s patents. On June 21 and 22, a Markman hearing was held in the matter, and the court heard extensive oral argument from both parties. MH&M was able to prove that three of the four patents in question had not infringed. Regarding the fourth patent, the court entered a series of claim construction rulings that were favorable to Alaris. McAndrews, Held & Malloy attorneys Timothy J. Malloy, David D. Headrick, Scott P. McBride, Wilhelm L. Rao and Stephen F. Sherry represented Alaris. # # # About McAndrews, Held & Malloy Founded in 1988, McAndrews, Held & Malloy is one of the nation’s preeminent legal resources on intellectual property, antitrust and technology matters, serving institutions ranging from major multinationals and start-ups to world-class colleges and universities. The firm’s technically trained attorneys have built an unparalleled record of litigation successes in jury trials, bench trials and ADR proceedings. In addition, McAndrews, Held & Malloy offers its clients services in the following areas: patent and trademark procurement and portfolio management, patent interferences, trademark oppositions and cancellations, international practice, intellectual property/technology opinions and investigations, due diligence and M&A support, technology licensing and joint ventures, and technology transfers and donations. Additional information can be found at http://www.mcandrews-ip.com. CONTACT: Randy Labuzinski / David Schulte Healy Communications 312/440-3900 rlabuzinski@healyco.com